HealthQuad, India’s healthcare venture capital fund, has announced the final close of its second fund, HealthQuad Fund-II, with a total subscription of $162 million (Rs 1,215 crores), more than 2.2 times greater than its target size at launch. 

MSD, the global biopharmaceutical company, led commitments from global financial investors, strategic institutions in pharma and healthcare, development financial institutions (DFI), funds of funds and large European conglomerates. The diverse investor base includes Ackermans & van Haaren (AvH), Teachers Insurance and Annuity Association of America (TIAA), Quilvest, HCL Corporation, DFIs such as CDC, Swedfund and SIDBI and India’s leading banking services company.

HealthQuad Fund-II is investing in 10 - 15 young private companies across high-growth segments of the healthcare sector in India, aiming to generate value as well as achieve deep social impact.